Cargando…

Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis

In multiple sclerosis (MS) autoaggressive T effector cells (Teff) are not efficiently controlled by regulatory T cells (Treg) but the underlying mechanisms are incompletely understood. Proinflammatory cytokines are key factors facilitating Teff activity in chronic inflammation. Here we investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinschek, Bettina, Lüssi, Felix, Haas, Jürgen, Wildemann, Brigitte, Zipp, Frauke, Wiendl, Heinz, Becker, Christian, Jonuleit, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796502/ https://www.ncbi.nlm.nih.gov/pubmed/24155968 http://dx.doi.org/10.1371/journal.pone.0077634

Ejemplares similares

Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013)

Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells
por: Trinschek, Bettina, et al.
Publicado: (2015)

Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
por: Wiendl, Heinz, et al.
Publicado: (2021)

Boosting regulatory T cell function by CD4 stimulation enters the clinic
por: Becker, Christian, et al.
Publicado: (2012)

B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis
por: Schwarz, Alexander, et al.
Publicado: (2016)

Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis
por: Deppe, Michael, et al.
Publicado: (2014)

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway
por: Helling, Bianca, et al.
Publicado: (2015)

Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells
por: Schlöder, Janine, et al.
Publicado: (2017)

Plasmacytoid Dendritic Cells Are Inefficient in Activation of Human Regulatory T Cells
por: Hubo, Mario, et al.
Publicado: (2012)

TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation
por: Melzer, Nico, et al.
Publicado: (2012)

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose
por: Wiendl, Heinz, et al.
Publicado: (2021)

Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
por: Jarius, Sven, et al.
Publicado: (2022)

Translating Treg Therapy in Humanized Mice
por: Hahn, Susanne A., et al.
Publicado: (2015)

Editorial: Current Concepts of Cellular and Biological Drugs to Modulate Regulatory T Cell Activity in the Clinic
por: Jonuleit, Helmut, et al.
Publicado: (2016)

Induction of Interleukin 10–Producing, Nonproliferating Cd4(+) T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells
por: Jonuleit, Helmut, et al.
Publicado: (2000)

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
por: Salmen, Anke, et al.
Publicado: (2023)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity
por: Liebmann, Marie, et al.
Publicado: (2021)

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Infectious Tolerance: Human CD25(+) Regulatory T Cells Convey Suppressor Activity to Conventional CD4(+) T Helper Cells
por: Jonuleit, Helmut, et al.
Publicado: (2002)

Intracerebral Human Regulatory T Cells: Analysis of CD4(+)CD25(+)FOXP3(+) T Cells in Brain Lesions and Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Fritzsching, Benedikt, et al.
Publicado: (2011)

High anti-JCPyV serum titers coincide with high CSF cell counts in RRMS patients
por: Schneider-Hohendorf, Tilman, et al.
Publicado: (2020)

Fingolimod treatment promotes regulatory phenotype and function of B cells
por: Grützke, Berit, et al.
Publicado: (2015)

Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Identification and Functional Characterization of Human Cd4(+)Cd25(+) T Cells with Regulatory Properties Isolated from Peripheral Blood
por: Jonuleit, Helmut, et al.
Publicado: (2001)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Ocrelizumab initiation in patients with MS: A multicenter observational study
por: Ellwardt, Erik, et al.
Publicado: (2020)

Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host Disease
por: Schlöder, Janine, et al.
Publicado: (2017)

Monitoring B-cell repopulation after depletion therapy in neurologic patients
por: Ellwardt, Erik, et al.
Publicado: (2018)

Supplementary medication in multiple sclerosis: Real-world experience and potential interference with neurofilament light chain measurement
por: Pape, Katrin, et al.
Publicado: (2020)

Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis
por: Laible, Mona, et al.
Publicado: (2016)

The Choroid Plexus Is Permissive for a Preactivated Antigen-Experienced Memory B-Cell Subset in Multiple Sclerosis
por: Haas, Jürgen, et al.
Publicado: (2021)

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS
por: Muthuraman, Muthuraman, et al.
Publicado: (2020)

Re-Defining Stem Cell-Cardiomyocyte Interactions: Focusing on the Paracrine Effector Approach
por: Mahapatra, Samiksha, et al.
Publicado: (2018)

Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells
por: Bacher, Nicole, et al.
Publicado: (2011)

The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021)

Alterations in Lymphocytic Metabolism—An Emerging Hallmark of MS Pathophysiology?
por: Greeck, Viktoria B., et al.
Publicado: (2023)

Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment
por: Haas, Jürgen, et al.
Publicado: (2019)

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
por: Chanvillard, Coralie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_21ubpk5llafotg1f5odpm9lhmk